Fitusiran clinical trials

Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IX

This study looks closely at a new medicine called fitusiran for men with haemophilia A or B. It aims to see how safe the medicine is over a long time and how well it prevents bleeding, as well as if it improves quality of life.